Status:
RECRUITING
Using tDCS in Speech-based Stroke Rehabilitation
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Apraxia of Speech
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation...
Eligibility Criteria
Inclusion
- Right-handed
- Monolingual (English)
- Single left-hemisphere CVA
- A minimum of six months post-stroke
- Clinical diagnosis of apraxia of speech
- Normal speech perception
- Passing score on the hearing screening.
Exclusion
- Diagnosis of laryngeal voice disorder
- Dysarthria
- History of speech impairment prior to CVA
- Presence of potential tDCS risk factors: damaged skin at site of stimulation;
- Presence of electrically or magnetically activated implant (including pacemaker);
- metal in any part of their body;
- history of medication-resistant epilepsy in the family;
- past history of seizures or unexplained spells of loss of consciousness.
Key Trial Info
Start Date :
January 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2026
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03452202
Start Date
January 11 2019
End Date
October 30 2026
Last Update
July 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016
2
Burke Rehabilitation Hospital
White Plains, New York, United States, 10605